02056, Norfolk, Massachusetts Prostate Cancer Score Hospital Score

The Hospital Score for the Prostate Cancer Score in 02056, Norfolk, Massachusetts is 49 when comparing 34,000 ZIP Codes in the United States.

**Prostate Cancer Care: A Review of Hospitals Near ZIP Code 02056 (Massachusetts)**

Navigating a prostate cancer diagnosis is daunting. Choosing the right hospital for treatment is a critical decision. This review focuses on hospitals near ZIP code 02056 (Millis, Massachusetts) and provides a fact-rich overview of their prostate cancer care offerings, including factors like CMS star ratings, ER wait times, specialty centers, and telehealth capabilities. This information aims to empower patients with the knowledge needed to make informed choices.

**Proximity and Primary Options**

Millis, MA (02056) is strategically located within a region boasting several renowned medical institutions. The primary hospitals within a reasonable driving distance offer comprehensive cancer care, including prostate cancer treatment. These include facilities in Boston, Worcester, and surrounding towns. The specifics below should be considered in conjunction with personal preferences, insurance coverage, and the advice of a primary care physician.

**Beth Israel Deaconess Medical Center (Boston)**

Beth Israel Deaconess Medical Center (BIDMC), a major teaching hospital affiliated with Harvard Medical School, is a significant player in the Boston healthcare landscape. It is located approximately 25 miles from Millis. BIDMC has a strong reputation in cancer care, including urology and oncology services.

BIDMC’s Cancer Center offers multidisciplinary care, bringing together urologists, medical oncologists, radiation oncologists, and other specialists. The hospital utilizes advanced diagnostic tools, including sophisticated imaging technologies. BIDMC actively participates in clinical trials, offering patients access to cutting-edge treatments.

While specific CMS star ratings can fluctuate, BIDMC generally maintains a strong rating, reflecting its commitment to patient safety and quality of care. Patients should check the most current CMS data for the most up-to-date information. Emergency room wait times can vary, but BIDMC typically strives to provide timely care. Information on current ER wait times is available online. Telehealth services are available, providing convenient access to consultations and follow-up appointments.

**Massachusetts General Hospital (Boston)**

Massachusetts General Hospital (MGH), another Harvard Medical School affiliate, is a world-renowned hospital, also located in Boston (approximately 25 miles from Millis). MGH is consistently ranked among the top hospitals in the nation. Its Cancer Center is a major center for cancer treatment and research.

MGH’s prostate cancer program is highly regarded, featuring a team of expert urologists, radiation oncologists, and medical oncologists. The hospital offers a full spectrum of treatment options, including surgery (robotic-assisted and open), radiation therapy (including advanced techniques like brachytherapy), and medical oncology (chemotherapy, hormone therapy, and targeted therapies). MGH is a leader in prostate cancer research and offers access to clinical trials.

MGH consistently receives high CMS star ratings, reflecting its commitment to patient safety and quality of care. Emergency room wait times can vary, but MGH generally strives to provide prompt care. Current ER wait times are available online. Telehealth services are widely available, enhancing patient access to care.

**Dana-Farber Cancer Institute (Boston)**

While not a general hospital, Dana-Farber Cancer Institute, located in Boston (approximately 25 miles from Millis), is a dedicated cancer center and a vital resource for prostate cancer patients. Dana-Farber is affiliated with Harvard Medical School and is a leader in cancer research and treatment.

Dana-Farber’s prostate cancer program is exceptionally strong. The institute offers a comprehensive approach to care, including cutting-edge diagnostic tools, advanced treatment options, and access to clinical trials. Patients benefit from the expertise of a dedicated team of specialists. Dana-Farber's focus is solely on cancer care, providing a concentrated expertise that is hard to match.

Dana-Farber does not have a CMS star rating as it is a specialized cancer institute. However, its reputation for excellence in cancer care is well-established. Emergency room wait times are not a primary concern, as most patients are seen through scheduled appointments. Telehealth services are available, offering convenient access to consultations and follow-up care.

**UMass Memorial Medical Center (Worcester)**

UMass Memorial Medical Center, located in Worcester (approximately 35 miles from Millis), provides comprehensive healthcare services, including cancer care.

UMass Memorial’s cancer center offers a range of prostate cancer treatment options, including surgery, radiation therapy, and medical oncology. The hospital has a team of experienced specialists. UMass Memorial is a regional referral center, providing care to a broad patient population.

CMS star ratings for UMass Memorial Medical Center should be checked for the most up-to-date information. Emergency room wait times can vary; information on current wait times is available online. Telehealth services are offered, enhancing patient access to care.

**Other Considerations**

Beyond the flagship hospitals, several other facilities within a reasonable driving distance offer prostate cancer care. These may include community hospitals and specialized clinics. These options can be valuable for patients seeking a more local or personalized approach to care.

**Specialty Centers and Programs**

Many hospitals have specialized centers or programs dedicated to urology and cancer care. These centers often offer advanced technologies, specialized expertise, and a multidisciplinary approach to treatment. Patients should inquire about the specific programs offered by each hospital.

**Telehealth and Remote Monitoring**

Telehealth services are becoming increasingly important in healthcare. Many hospitals offer telehealth consultations, follow-up appointments, and remote monitoring programs. These services can enhance patient convenience and access to care, especially for patients who live a distance from the hospital.

**ER Wait Times**

Emergency room wait times can be a significant factor for patients needing urgent care. Patients should check the current wait times for each hospital before visiting the ER. This information is usually available online or through the hospital's website.

**Clinical Trials**

Participation in clinical trials can provide access to cutting-edge treatments and contribute to advancements in prostate cancer care. Patients should inquire about clinical trial opportunities at each hospital.

**Insurance and Financial Considerations**

Insurance coverage and financial considerations are crucial. Patients should verify that their insurance plan is accepted by the hospital and that their treatment will be covered. They should also inquire about the hospital's financial assistance programs if needed.

**Making Your Choice**

Choosing the right hospital for prostate cancer treatment is a personal decision. Patients should consider their individual needs, preferences, and the factors outlined above. Consulting with a primary care physician and seeking second opinions from specialists is highly recommended.

**Conclusion**

The region near ZIP code 02056 (Millis, MA) is fortunate to have access to several leading hospitals with strong prostate cancer programs. Beth Israel Deaconess Medical Center, Massachusetts General Hospital, Dana-Farber Cancer Institute, and UMass Memorial Medical Center offer comprehensive care, advanced technologies, and experienced specialists. Patients should carefully evaluate their options, considering factors such as CMS star ratings, ER wait times, specialty centers, telehealth capabilities, and insurance coverage. By gathering this information and consulting with their healthcare providers, patients can make informed decisions and receive the best possible care for their prostate cancer. This review provides a starting point for that important journey.